COVID-19 Associated Coagulopathy and Thrombotic Complications
The SARS-CoV-2 virus caused a global pandemic within weeks, causing hundreds of thousands of people infected. Many patients with severe COVID-19 present with coagulation abnormalities, including increase D-dimers and fibrinogen. This coagulopathy is associated with an increased risk of death. Furthe...
Main Authors: | Zoubida Tazi Mezalek, Hajar Khibri, Wafaa Ammouri, Majdouline Bouaouad, Soukaina Haidour, Hicham Harmouche, Mouna Maamar, Mohamed Adnaoui |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-08-01
|
Series: | Clinical and Applied Thrombosis/Hemostasis |
Online Access: | https://doi.org/10.1177/1076029620948137 |
Similar Items
-
Systemic lupus erythematosus associated with sickle-cell disease: a case report and literature review
by: Maamar Mouna, et al.
Published: (2012-10-01) -
Venous thromboembolism and hyperhomocysteinemia as first manifestation of pernicious anemia: a case series
by: W. Ammouri, et al.
Published: (2017-09-01) -
Thrombotic and Hypercoagulability Complications of COVID-19: An Update
by: Shibeeb S, et al.
Published: (2021-08-01) -
Arterial thrombotic complications in COVID-19 patients
by: Stef Levolger, MD, PhD, et al.
Published: (2020-09-01) -
Coagulopathy and COVID-19
by: Onur Yazici, et al.
Published: (2020-01-01)